The FDA recently approved trospium (Sanctura, Indevus Pharmaceuticals/Odyssey Pharmaceuticals) for the treatment of OAB with symptoms of urge urinary incontinence, urgency, and urinary frequency. The product launch of trospium is expected to take place during the third quarter of 2004.
New study finds it pays to base pharmacists up on hospital wards
Even thought pharmacists are experiencing more on-the-job stress, they are still satisfied with their jobs, according to a national survey of 1,737 practicing R.Ph.s.
Promoting patient compliance can generate new business for community R.Ph.s
Thoracic society meeting sees the release of new guidelines for the treatment of chronic obstructive pulmonary disease.
Women living in rural areas are in special need of pharmaceutical care
This installment deals with the problem of physicians who don't enter their DEA number on their Rxs
HIPAA's security standards will take effect in about a year and pharmacists are starting to conduct a risk analysis to prepare for the new requirements
2004 Index of Articles
Breaking News for June 7, 2004
FDA holds meeting to study issue of plastic vials and their association with drug errors
Overview of FMI Pharmacy meeting in Chicago, 2004
John Fagan, vp Ahold, talks about the new Medicare Rx bill and Rx discount cards.
Pharmacy reacts to FDA proposal requiring MedWatch number to be listed on Rx and OTC drugs
Manufacturers and regulators will have a tough time battling drug counterfeiters
New trend: Pharmaceutical companies offer freebies and money back guarantees on drugs
David Brushwood gives a tongue-in-cheek account of how to create the worst-possible pharmacy
Reporting medication errors has not translated into safer systems of patient care, according to Bruce Lambert, Ph.D., University of Illinois at Chicago department of pharmacy practice.
Seniors can compare drug price increases with the inflation rate on AARP's new Web site
Similarities in labeling/packaging can lead to dispensing errors
Lehigh Valley Hospital explores risk sharing contracts with pharma manufacturers
How to prepare for the new security standards, which take effect next year
While urinary tract infections in women are the second most frequent reason antibiotics are prescribed for women, many ignore symptoms or don't take steps necessary to prevent infection.
Breaking News for May 17, 2004
Certain pancreatic drugs could be withdrawn from market unless their manufacturers go through NDA process
Abstract of speech given by Mary Sammons at NACDS Annual Meeting 2004
Manufacturers keep churning out low carb entries that can be profitable for pharmacies
AMCP meeting sees debate between two laywers on whether contracts are public or private information
Arxcel Rx benefit research survey 2004
As part of the Medicare discount card and Medicare drug benefit law, a new Web site is being established that compares drug prices